Development of the Endocardium by Harris, Ian S. & Black, Brian L.
RILEY SYMPOSIUM
Development of the Endocardium
Ian S. Harris • Brian L. Black
Received: 7 January 2010/Accepted: 17 January 2010/Published online: 5 February 2010
 The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract The endocardium, the endothelial lining of the
heart, plays complex and critical roles in heart develop-
ment, particularly in the formation of the cardiac valves
and septa, the division of the truncus arteriosus into the
aortic and pulmonary trunks, the development of Purkinje
ﬁbers that form the cardiac conduction system, and the
formation of trabecular myocardium. Current data suggest
that the endocardium is a regionally specialized endothe-
lium that arises through a process of de novo vasculogen-
esis from a distinct population of mesodermal cardiogenic
precursors in the cardiac crescent. In this article, we review
recent developments in the understanding of the embryonic
origins of the endocardium. Speciﬁcally, we summarize
vasculogenesis and speciﬁcation of endothelial cells from
mesodermal precursors, and we review the transcriptional
pathways involved in these processes. We discuss the
lineage relationships between the endocardium and other
endothelial populations and between the endocardium and
the myocardium. Finally, we explore unresolved questions
about the lineage relationships between the endocardium
and the myocardium. One of the central questions involves
the timing with which mesodermal cells, which arise in the
primitive streak and migrate to the cardiac crescent,
become committed to an endocardial fate. Two competing
conceptual models of endocardial speciﬁcation have been
proposed. In the ﬁrst, mesodermal precursor cells in the
cardiac crescent are prespeciﬁed to become either endo-
cardial or myocardial cells, while in the second, fate
plasticity is retained by bipotential cardiogenic cells in the
cardiac crescent. We propose a third model that reconciles
these two views and suggest future experiments that might
resolve this question.
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Overview of Cardiogenesis
The cardiovascular system is the ﬁrst organ system to form
and function in the vertebrate embryo. The heart forms
when regions of bilaterally symmetrical cardiac progenitor
cells in the anterior lateral mesoderm fuse at the ventral
midline to form a linear tube, which is continuous with the
dorsal aorta anteriorly and the cardinal veins posteriorly
[5]. The heart tube at the time of its formation is a two-
layered structure, composed of an inner endothelial layer
and an outer myocardial layer. The myocardial layer will
form the muscular walls of the heart and the muscular
portions of the interventricular septum. The endothelial
layer comprises the endocardium [1, 4, 6, 54].
In addition to forming an endothelial layer within the
heart that is contiguous with the rest of the vasculature, the
endocardium has several other essential functions during
heart development. For instance, the endocardium plays an
important role in signaling to cardiomyocytes and is
required for proper formation of trabecular myocardium
[60, 65]. It is also involved in the signaling required for
transdifferentiation of myocytes into the Purkinje ﬁber
cells that comprise much of the cardiac conduction system
[41, 42]. In addition, cells from speciﬁc regions of the
endocardium will undergo endocardial-to-mesenchymal
transformation (EMT) to form the endocardial cushions
[12]. The endocardial cushions give rise to several
important structures within the heart, including the valve
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septum, and the atrial septum [51, 57]. In addition, endo-
thelial-derived cells in the cardiac cushions function, along
with cells of neural crest origin, to separate the common
outﬂow tract (OFT) into the pulmonary artery and aorta
[27, 38, 57]. Despite the many essential functions of the
endocardium during development and in postnatal cardiac
function, much remains to be learned about the develop-
ment and embryonic origins of the endothelial progenitor
cells that will give rise to the endocardium.
Speciﬁcation of Endothelial Cells
Vasculogenesis, the de novo formation of blood vessels,
occurs necessarily before the onset of blood circulation. In
amniotes, endothelial and hematopoietic cells ﬁrst appear
at the same time in the extraembryonic yolk sac and are
thought to arise from a common mesodermal precursor, the
hemangioblast [48, 67]. Vasculogenesis begins when he-
mangioblasts coalesce to form blood islands. The outer
cells in the blood islands ﬂatten as they differentiate into
endothelial cells, while the inner cells differentiate into
hematopoietic progenitors [20, 50]. Ultimately, these cells
will form the extraembryonic yolk sac vasculature and the
blood cells contained within it [20].
De novo vasculogenesis also occurs at multiple discrete
sites within the embryo proper, including the paired dorsal
aortae, within the heart tube, in the neural plexus, and in
the primary vascular plexus [14, 20, 50]. In the embryo,
mesoderm-derived endothelial precursors called angio-
blasts aggregate to form the dorsal and ventral aortae and
the vitelline vessels [20]. Endocardial precursors arise via a
similar process of de novo vasculogenesis within the car-
diac crescent and are subsequently arranged into a vascular
tube during ventral morphogenesis [1, 28]. The precise
timing of speciﬁcation of these precursors remains
incompletely understood and is discussed below.
Multiple studies in ﬁsh, birds, and mammals have sug-
gested an intimate relationship between endothelial and
hematopoietic lineages. Lineage-tracing studies performed
in zebraﬁsh have revealed that blood cells and endothelial
cells are derived from common precursors termed heman-
gioblasts in the ventral marginal zone of the blastula [33,
58]. In the mouse, hemangioblasts have been identiﬁed by
coexpression of the mesodermal gene brachyury (Bry) and
the VEGF receptor, Flk-1 [18]. The relationship between
vasculogenic and hematopoietic precursors has recently
been found to be even more complex: genetic fate-mapping
studies in the mouse revealed that an endothelial-speciﬁc
Cre transgene resulted in the genetic labeling of a large
number of hematopoietic cells in the adult bone marrow
[69]. These ﬁndings lend support to the concept, previously
suggested by work in avian embryos, of a population of
hemogenic endothelial cells that have the capacity to give
rise to blood [29, 69].
After formation of the embryonic and extraembryonic
vasculature, the initial primitive vessels are extensively
remodeled into mature vessels through a complex process
termed angiogenesis [20, 49, 50]. In addition, smooth
muscle cells or pericytes are recruited to the vessel walls
from surrounding mesenchyme [24]. During angiogenesis
and vascular remodeling, vessels expand, coalesce, branch,
and become specialized as arteries, veins, and capillaries
[20, 24, 25].
Embryonic Origin of the Endocardium and Its
Relationship to Other Endothelial Cells
The unique location and specialized functions of the
endocardium have led some investigators to question
whether it represents a unique and molecularly distinct
population of cells or rather simply a spatially restricted
subpopulation of endothelium. Several genetic models have
offered some insight into this question. Tie and Tie2, two
structurally related receptor tyrosine kinases, are required
throughout the vasculature during late organogenesis and
during postnatal life in mice [63]. Tie
-/-;Tie2
-/- embryos
display normal extracardiac vasculogenesis but have pro-
found cardiac defects, including deﬁcient endocardium, and
Tie
-/-;Tie2
-/- endothelial cells contribute normally to all
vascular structures except the endocardium [52]. Similar
results were observed in cloche mutant zebraﬁsh, which
have structurally normal endothelium of the dorsal aortae
and cardinal veins, despite the absence of the endocardium
[59]. Notably, cloche is also required for formation of
hematopoietic stem cells, as well as for formation of the
endocardium [59]. Importantly, and in contrast to the above
examples, no factors or genes have been identiﬁed to date to
be dispensable for endocardial speciﬁcation but to be
required for endothelial speciﬁcation elsewhere in the
embryo, suggesting that endocardial progenitors comprise a
spatially restricted subset of a larger endothelial precursor
population.
The endocardium appears to be unique among endothe-
lial tissues in that it arises through de novo vasculogenesis
from a population of precardiac progenitors, marked by Flk-
1 expression in the late primitive streak, which also give rise
to cardiomyocytes [30]. Recent work has reﬁned our
understanding of the clonal origins of the endocardium.
Embryonic stem cells derived from an Nfatc1-nuc-lacZ
bacterial artiﬁcial chromosome (BAC) transgenic mouse
line were used to generate embryoid bodies, which could be
separated into three distinct populations on the basis of
expression levels of E-cadherin (ECD) and Flk1:
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highFlk1
low, ECD
lowFlk1
high, and ECD
lowFlk1
low [43].
The ECD
lowFlk1
high population represents the hemangio-
blast population [43]. Importantly, only the ECD
lowFlk1
low
population demonstrated detectable X-gal staining (indic-
ative of Nfatc1 expression), suggesting that the endocar-
dium is derived from this non-hemangioblast population
[43]. Interestingly, the ECD
lowFlk1
low population also dis-
played markers of vascular differentiation, including Cdh5
(VE-cadherin) and CD31 (Pecam1) and markers of myo-
cardial differentiation, including Nkx2-5, b-MyHC, cTnT,
GATA4, and Mef2c [43], again supporting the notion that
this population gives rise to both myocardial and endocar-
dial cells. These data are consistent with the recent dis-
covery that the hemangioblast and cardiac potential of
embryonic stem (ES) cell-derived embryoid bodies segre-
gated to two distinct populations, Bry
?/Flk1
? and Bry
?/
Flk1
-, respectively, based on cell surface marker expres-
sion [32]. It was later found that the Bry
?/Flk1
- population
generates a second Flk1
? population with robust cardiac
potential that contains progenitors of cardiomyocytes, vas-
cular smooth muscle cells, and endothelial (endocardial)
cells [17]. Taken together, these data suggest that endo-
cardial cells arise, at least in part, from a cardiovascular
progenitor population distinct from the hemangioblasts that
give rise to other endothelial subtypes.
The endocardium is known to express lineage-speciﬁc
markers in a pattern distinct from other endothelial cell
types. For example, Nfatc1 is speciﬁcally expressed in the
endocardium, with transcripts detectable at the time of
initiation of endocardial differentiation in the primary
heart-forming ﬁeld at E7.5 and intracellular protein
detectable at the linear heart tube stage at E8.5 [13].
Interestingly, despite its intranuclear location during early
endocardiogenesis, NFATc1 does not appear to be required
for endocardial speciﬁcation or proliferation, although its
activity is critical during later cardiac development and
valvulogenesis [13, 53]. Thus, all of the observations to
date support a model in which the endocardium is a spa-
tially restricted population of endothelium, arising as a
result of de novo vasculogenesis from precursor cells
present in the cardiac crescent. Furthermore, the observa-
tions to date suggest that highly related, but distinct,
genetic programs, involving overlapping subsets of factors,
control the development of the endothelial cells that will
comprise the endocardium versus endothelial cells located
elsewhere in the embryo.
Relationship Between Endocardium and Myocardium
The lineage relationship between endocardial and myo-
cardial cells remains unresolved. Speciﬁcally, while it is
clear that endocardial and myocardial cells share a
common progenitor, it is not clear whether these progeni-
tors are present in the early heart ﬁeld within the anterior
lateral mesoderm. Two basic models of lineage determi-
nation in the heart have been proposed [16, 28, 35]. The
ﬁrst model is based primarily on observations in avian and
ﬁsh embryos and postulates that cells in the cardiac
mesoderm are prespeciﬁed in the primitive streak, prior to
migration to the cardiac crescent, to become either myo-
cardium or endocardium (Fig. 1)[ 11, 66]. The second
model is largely based on work performed in mouse
embryos or using cells derived from mammalian embryos
and suggests that endocardial and myocardial cells share a
common progenitor within the cardiac mesoderm and that
these bipotential (or multipotential) cells maintain fate
plasticity until a much later time in development than the
prespeciﬁcation model (Fig. 2)[ 7, 30, 39, 46].
Fig. 1 A prespeciﬁcation model for endocardial cells. Data obtained
primarily from avian and ﬁsh models suggest that mesodermal cells
are prespeciﬁed in the primitive streak before migration to the cardiac
crescent to adopt either an endocardial or a myocardial fate.
Endocardial precursors then receive inductive cues from the under-
lying endoderm to differentiate into cells with an endothelial
phenotype
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When They Migrate from the Primitive Streak to the
Cardiac Crescent
In an elegant set of lineage-tracing experiments, Mikawa
and coworkers introduced b-gal-expressing viral particles
into the mesodermal layer of gastrulating chick embryos at
Hamburger-Hamilton (HH) stage 4 (11). When the
embryos were examined at HH stage 10, b-gal
? cells were
seen in both the endocardium and the myocardium. How-
ever, individual patches of b-gal
? cells, thought to have
arisen from individual infected precursors, were seen to
contain either myocardial or endocardial cells, but never
both [11]. The latter result was observed even at viral titers
that would only result in the infection of individual cells.
From these results, Mikawa and coworkers concluded that
individual cells in the cardiac mesoderm were already
speciﬁed to give rise either to myocardial cells or to
endocardial cells [11]. In a follow-up set of similar
experiments, the same group infected cells in the primitive
streak at HH stage 3 with a b-gal-encoding replication-
deﬁcient virus. Again, when they examined embryos at HH
stage 10, they observed similar results as with the previous
set of experiments. Individual b-gal
? patches of labeled
cells, presumably derived from just a single infected pro-
genitor cell, contained either endocardial cells or myocar-
dial cells, but never both [66]. As with their previous study,
these results support a model in which precardiac meso-
derm cells are prespeciﬁed to either the myocardial or the
endocardial lineage prior to migration through the primi-
tive streak (Fig. 1).
Similarly, in a series of cell-labeling experiments in
zebraﬁsh, it was found that the majority of cells within the
cardiogenic region did not give rise to endocardial cells.
Rather, a subset of mesoderm precursors located in the
ventral region of the heart ﬁeld was found to give rise to
endocardial cells [33]. As was observed in the chick
experiments described above, individual cells labeled in
the heart ﬁeld never gave rise to both myocardium and
endocardium.
Model 2: Precardiac Mesoderm in the Cardiac Crescent
Contains Multipotential Cells That Can Give Rise to
Both Endocardium and Myocardium
In contrast to the studies described above, in which
endocardial cells are prespeciﬁed in the cardiac meso-
derm, studies performed primarily in mouse embryos have
suggested a different model in which mesodermal pre-
cursor cells in the cardiac crescent maintain fate plasticity
and can give rise to both myocardium and endocardium
[39]. Molecular marker analyses and Cre-based fate
mapping approaches in mice have resulted in the identi-
ﬁcation of markers of the cardiac lineage that begin to be
expressed in the mesoderm of the cardiac crescent after
the cells have migrated through the primitive streak.
Several of these markers label cells that give rise to
descendents present in both the myocardium and the
endocardium [9, 39, 64].
Fig. 2 A model for multipotent progenitor cells in the cardiac
crescent. Data acquired primarily from mouse fate-mapping studies
and ex vivo approaches using cells from mouse embryos suggest that
there are multipotential progenitors in the cardiac crescent that can
then be speciﬁed to adopt endocardial, myocardial, or vascular
smooth muscle cell fates
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mouse embryos demonstrated that Isl1
Cre-marked cells,
which are ﬁrst apparent in the cardiac crescent, give rise to
both myocardial and endocardial cells [9]. This observation
supports the notion that these two cell types arise from a
common progenitor in the cardiac crescent, although it
does not exclude the alternative hypothesis that Isl1 may be
simultaneously expressed in distinct progenitors for each of
these lineages. Similarly, Verzi et al. examined the activity
of a Cre-dependent reporter in which Cre was expressed
under the control of anterior heart ﬁeld (AHF)-speciﬁc
regulatory elements from the Mef2c gene and found that
both endocardial and myocardial cells were marked by the
activity of the transgene [64]. Again, this is consistent with
the notion that these two tissues share a common progen-
itor in the cardiac crescent but allows the possibility that
the activity of the Mef2c-AHF-Cre transgene might also
independently mark two discrete progenitor populations.
Likewise, Chien and colleagues used genetic fate-mapping
techniques in mice to identify a subset of multipotent
cardiovascular progenitors with the transcriptional signa-
ture Isl1
?; Flk1
?; Nkx2-5
? that gave rise to multiple cell
types in vivo and were able to generate cardiac muscle,
smooth muscle, and endothelial cells in vitro (Fig. 2)[ 44].
More recent work has further elucidated the lineage
relationships between myocardium and endocardium in the
mouse. Nkx2-5 is one of the earliest markers of the myo-
cardial lineage, ﬁrst expressed at the cardiac crescent stage
[22, 23, 31, 36, 56]. Germline deletion of Nkx2-5 results in
profound cardiac defects, characterized in part by complete
absence of the endocardial cushions [37, 62]. These
observations, combined with the fate-mapping and lineage
analyses discussed in the previous paragraph, provide fur-
ther evidence for a model in which myocardial and endo-
cardial cells arise from a common progenitor cell in the
precardiac mesoderm [35]. Alternatively, these data are
also consistent with the notion that Nkx2-5
? progenitor
cells in the cardiac crescent do not represent a uniform
population of bipotential cells but, rather, are composed of
at least two distinct subpopulations that have been pre-
speciﬁed to adopt myocyte and endocardial fates but that
cannot be resolved on the basis of known markers. This
alternative interpretation of the majority of these mouse
experiments would be more consistent with the chick and
zebraﬁsh data supporting prespeciﬁcation of endocardial
and myocardial progenitors within the precardiac meso-
derm, as discussed in the last section.
Further support for the notion that cardiac progenitor
cells in the crescent remain multipotential and give rise to
both myocytes and endocardial cells is provided by recent
work examining the regulation of the Ets-related protein
Etv2 (Etsrp71, ER71) gene [19]. Etv2 has been identiﬁed
recently as a major master control gene for endothelial
speciﬁcation [15, 19, 34, 61]. Interestingly, Etv2 regulation
in the endocardium appears to be under direct control of
Nkx2-5, a cardiac master regulator [2, 19, 36]. Although
these results do not directly address the potential or fate of
progenitors within cardiogenic mesoderm, the observation
that a cardiac master regulator activates an endothelial
master regulator is consistent with the idea that an early
program involving Nkx2-5 sets up both the endocardial and
the myocardial programs and suggests that the endocar-
dium arises secondarily from a subset of cardiogenic pro-
genitors via a cell-autonomous effect of Nkx2-5.
Because of the limited number and relative inaccessi-
bility of cardiogenic mesoderm cells in the early mouse
embryo, ES cell-based models have also been used
extensively to investigate the early fate decisions of car-
diogenic mesoderm. Kattman and colleagues examined in
vitro differentiation of an ES cell line with a GFP reporter
gene targeted to the mesoderm speciﬁcation gene brachy-
ury [18, 26, 30]. As ES cells were differentiated, some
expressed GFP, indicating that they had adopted a meso-
derm fate. These GFP-positive cells were all initially
Flk1
-, but a subset induced expression of the endothelial
marker gene Flk1 and this induction could be augmented
by addition of the endothelial growth factor VEGF to the
culture medium [30]. Importantly, some Flk1
? cells were
observed to form aggregates of beating cells that expressed
the cardiac-speciﬁc marker cTnT, indicating that these
Flk1
? cells had the capacity to form either endothelial cells
or cardiomyocytes [30].
In another study, Masino and colleagues used ﬂuores-
cence-activated cell sorting (FACS) to isolate cells
expressing YFP under control of an enhancer element from
the Nkx2-5 locus at the cardiac crescent stage, at the linear
heart tube stage, and during cardiac looping, and they
performed transcriptome-wide expression proﬁling [39].
These studies showed that these Nkx2-5
? cardiac precursor
cells expressed markers of both cardiac myocyte differen-
tiation and endothelial differentiation, lending credence to
the notion that the precardiac mesoderm contains multi-
potential cells with the capacity to give rise to at least two
descendent types, myocardial and endothelial cells [39].
It is important to note that cells with the capacity to give
rise to both endothelial and myocardial cells are not
restricted to mammalian systems. Several laboratories have
also found evidence of bipotential mesoderm precursors in
avian cells as well. The QCE-6 cell line, derived from
explants of Japanese quail embryos collected at HH stage
4, can differentiate into both endothelial and myocardial
cells [55], suggesting that a degree of plasticity exists in
those progenitor cells as well. In addition, overexpression
of the bHLH transcription factor Scl/Tal1 together with the
Lim-homeodomain transcription factor Lmo2 in early
zebraﬁsh embryos has been shown to result in an expansion
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myocardial differentiation, suggesting a shared precursor
population [21].
Thus, it remains unclear whether mesodermal cells in
the cardiac crescent represent a homogeneous population
of bipotential cardiac progenitors or, rather, a heteroge-
neous population of progenitors that have been pre-
speciﬁed to adopt either a myocardial or an endocardial
fate. Future studies will be required to determine whether
these two models can be reconciled and to clarify this
issue.
Transcription Factors Involved in Endocardial
Development
Regardless of whether endocardial progenitors are pre-
speciﬁed at the time they enter the cardiac crescent or
whether cells maintain signiﬁcant plasticity until later in
development, it is clear that the endocardium develops
from a subset of cardiogenic precursors within the anterior
lateral mesoderm [43]. In order to understand how these
cardiogenic cells enter either the myocardial or the endo-
cardial fate, it is critical to examine the transcriptional
networks involved in these fate decisions. While endocar-
dial cells arise from a distinct population of cardiovascular
precursors, their speciﬁcation appears to involve a genetic
program shared with other endothelial populations. Several
transcription factors have been shown to be required for
both endothelial and endocardial speciﬁcation. For exam-
ple, Etv2 and Scl/Tal1, both key early regulators of endo-
thelial development, are also required for endocardial
speciﬁcation [8, 14, 19]. These observations support the
view that the endocardium is simply a spatially restricted
subpopulation of endothelium. However, a limited number
of transcription factors are expressed speciﬁcally in the
endocardium, and examination of these and their relation-
ship to established cardiac programs has led to an enhanced
understanding of the unique nature of the endocardium.
The GATA family of zinc-ﬁnger proteins has been
shown to be critical for cardiac development [10]. Al
Moustafa and Chalifour found that mesodermal cells could
be differentiated in vitro by treatment with retinoic acid
[3]. Upon treatment, these cells attenuate expression of the
pan-mesoderm markers Brachyury and GATA4 and begin
to express GATA5 [47]. At the same time, the transcription
factor NFATc1 is translocated to the nucleus, where it can
participate in transcriptional activation[47]. In vitro trans-
activation assays using a GATA-responsive reporter con-
struct showed that GATA5 and NFATc1 synergistically
activate endocardial gene expression [47]. This cooperative
activation by GATA and NFAT factors lends support to the
notion that the endocardium develops within a ﬁeld of
cardiac progenitors as a molecularly distinct endothelial
subpopulation in response to cardiac-speciﬁc cues.
Etv2 is an important endothelial and hematopoietic
determination factor and has been shown recently to play a
fundamental role in the transcriptional program controlling
development of the endothelium, including the endocar-
dium [15, 19, 34, 61]. Etv2-null embryos are normal at
E8.5 but are nonviable between E9.0 and E10.0 and have
no identiﬁable endocardium or endothelium [19]. Inter-
estingly, Etv2 appears to be activated directly by Nkx2-5 in
the progenitors that will give rise to the endocardium [19].
This result suggests that myocardial speciﬁcation (or a
more general speciﬁcation of cardiac progenitors) may
precede endocardial speciﬁcation and Etv2 activation.
Etv2, in turn, bound to the promoter region of the Tie2 gene
in vivo and transactivated it in culture [19]. These data
suggest that, while sharing a basic transcriptional network
with other endothelial types, the endocardium is unique in
that it arises from a distinct cardiac precursor population
and that the genetic program controlling its speciﬁcation is
subordinate to a cardiogenic program in a transcriptional
hierarchy responsible for cardiovascular development.
Future Directions
As outlined above, a central question in understanding
endocardial development is whether the fate of precursor
cells in the mesoderm is prespeciﬁed by the time they
arrive in the cardiac crescent or whether these precursors
retain some fate plasticity. On the whole, in vivo avian
models have supported the prespeciﬁcation model, while in
vitro systems, primarily using mammalian cells, have lent
support to the plasticity model [66]. A shortcoming of the
existing in vivo work in mammalian systems is that it has
failed to exclude the possibility that available markers
might not be able to resolve potential component subpop-
ulations within the cardiac crescent. A trivial explanation
for discrepancies between the two models is that there may
be inherent differences in the model organisms. However,
another way of reconciling the two models is to postulate
that cardiogenic precursors do indeed retain plasticity
within the cardiac crescent, but that their fate decisions
once they arrive in the crescent are constrained by posi-
tional cues. In this way, bipotential precursor cells labeled
in situ will be seen giving rise to only one cell type, but can
be induced to differentiate into both endocardium and
myocardium when removed from the embryo (and the
corresponding positional cues within the embryo) and
cultured ex vivo.
To address the issue of whether bipotential (or multi-
potential) progenitor cells within the nascent heart ﬁeld
are restricted in their fate due to positional information,
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labeled with 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbo-
cyanine perchlorate (diI) and transplanted to a more dorsal
position in chick embryos. Subsequent identiﬁcation of the
label in myocardial cells would suggest that the cardiac
crescent contains bipotential progenitors whose fate deter-
mination is constrained by positional cues. Additionally, the
role of positional cues and possible species differences
could be addressed in mouse embryos by retrospective fate
mapping, as has been done so elegantly to map contribu-
tions of myocardial progenitors to the heart [40]. Speciﬁ-
cally, an nlaacZ reporter construct could be targeted to the
Nkx2-5 locus in mouse. As has been shown previously, this
reporter contains a lacZ reporter gene with a frameshift
mutation (hence the name laacZ) and is inactive unless a
rare intragenic recombination event occurs [40]. In the
event of such a recombination, which restores functional
lacZ expression, all progeny of the cell in which recombi-
nation occurred will be labeled [40]. Clonal labeling of both
endocardial and myocardial cells in the neonatal heart
would provide compelling evidence that individual Nkx2-
5
? precursors in the cardiac crescent can give rise to both
lineages.
Additionally, a genetic approach could be taken to
address the possibility that a subset of cardiovascular
progenitors becomes speciﬁed in the cardiac crescent to
adopt an endothelial cell fate under the control of the
cardiac regulator Nkx2-5. A transgenic mouse line has
been published that expressed Cre recombinase under the
control of an enhancer element from the Nkx2-5 locus
[45, 68]. Cre expression in these mice is ﬁrst detected in
cardiovascular progenitors of the cardiac crescent and is
restricted to the myocardium after cardiac looping [68].
This Cre transgenic line could be used to create a con-
ditional deletion of Etv2. If such a deletion resulted in
disruption of the endothelial program in these cardiovas-
cular progenitors and a defect in the endocardium, it
would clarify two of the central questions of endocardial
development. First, it would lend support to the notion
that the cardiac master regulator Nkx2-5 and the endo-
thelial master regulator Etv2 act in a hierarchical fashion
to drive endocardial development. Second, it would shed
light on the timing of endocardial speciﬁcation, providing
clear evidence that the endothelial program is not initiated
until after Nkx2-5 begins to function in the cardiac
crescent.
Implications
The endocardium plays several well-established roles in
the development of the heart. It serves as the source of
mesenchymal cells in the endocardial cushions that give
rise to the structural elements of the cardiac valves as well
as the atrial and membranous ventricular septa. It also
participates in less well-appreciated ways in other aspects
of cardiovascular development, including the formation of
the cardiac conduction system and in proper myocardial
trabeculation [41, 60, 65]. Given the toll of pediatric dis-
ease represented by valvular abnormalities, septal defects,
conduction system abnormalities, and ventricular non-
compaction, the role of the endocardium during develop-
ment is critically important clinically. Thus, a more
detailed appreciation of the molecular mechanisms of
endocardial development is essential to gain a more
nuanced understanding of human developmental defects
and eventually may offer the hope of developing novel
therapeutic strategies for congenital heart defects.
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